Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Apyx Medical (APYX) Receivables Refunds (2019 - 2023)

Apyx Medical's Receivables Refunds history spans 5 years, with the latest figure at $7.8 million for Q2 2023.

  • For Q2 2023, Receivables Refunds rose 1.44% year-over-year to $7.8 million; the TTM value through Jun 2023 reached $7.8 million, up 1.44%, while the annual FY2022 figure was $7.5 million, 1.27% down from the prior year.
  • Receivables Refunds reached $7.8 million in Q2 2023 per APYX's latest filing, roughly flat from $7.8 million in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $7.8 million in Q1 2023 to a low of $426000.0 in Q4 2019.
  • Average Receivables Refunds over 5 years is $6.9 million, with a median of $7.6 million recorded in 2021.
  • Peak YoY movement for Receivables Refunds: soared 1696.71% in 2020, then fell 1.42% in 2022.
  • A 5-year view of Receivables Refunds shows it stood at $426000.0 in 2019, then skyrocketed by 1696.71% to $7.7 million in 2020, then dropped by 0.16% to $7.6 million in 2021, then decreased by 1.27% to $7.5 million in 2022, then increased by 2.74% to $7.8 million in 2023.
  • Per Business Quant, the three most recent readings for APYX's Receivables Refunds are $7.8 million (Q2 2023), $7.8 million (Q1 2023), and $7.5 million (Q4 2022).